Abstract
In food science the Maillard reaction is well known to cause degradation of amino acids and an overall decrease in the nutritional value of foods that have been subjected to heat in processing. There has been evidence more recently of the endogenous formation of some Maillard reaction products (MRPs) in biological systems and their association with pathophysiological conditions including diabetes, renal disease and cardiovascular disease. Several studies have suggested that dietary MRPs increase the in vivo pool of MRPs after intestinal absorption and contribute to the development of diabetes and related complications. This review focuses on the animal and human studies which have assessed the eventual implications of dietary MRPs on human health, highlighting the different diets tested, the experimental designs and the biomarkers selected to estimate the health effects. The results of these studies are compared to those of the recently published ICARE study. In this latter study an accurate determination of the MRP content of the diets was achieved, allowing the calculation of the contribution of individual food groups to daily MRP intakes in a regular western diet.
Similar content being viewed by others
References
Agalou S, Ahmed N, Babaei-Jadidi R, Dawnay A, Thornalley PJ (2005) Profound mishandling of protein glycation degradation products in uremia and dialysis. J Am Soc Nephrol 16:1471–1485
Ahmed MU, Thorpe SR, Baynes JW (1986) Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261:4889–4894
Ahmed N, Thornalley PJ, Luthen R, Haussinger D, Sebekova K, Schinzel R, Voelker W, Heidland A (2004) Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis. J Hepatol 41:913–919
Ahmed N, Mirshekar-Syahkal B, Kennish L, Karachalias N, Babaei-Jadidi R, Thornalley PJ (2005) Assay of advanced glycation endproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection. Mol Nutr Food Res 49:691–699
Assar SH, Moloney C, Lima M, Magee R, Ames JM (2009) Determination of Nepsilon-(carboxymethyl)lysine in food systems by ultra performance liquid chromatography-mass spectrometry. Amino Acids 36:317–326
Bergmann R, Helling R, Heichert C, Scheunemann M, Mäding P, Wittrisch H, Johannsen B, Henle T (2001) Radio fluorination and positron emission tomography (PET) as a new approach to study the in vivo distribution and elimination of the advanced glycation endproducts N epsilon-carboxymethyllysine (CML) and N epsilon-carboxyethyllysine (CEL). Nahrung 45:182–188
Birlouez-Aragon I, Morales F, Fogliano V, Pain J-P (2010a) The health and technological implications of a better control of neoformed contaminants by the food industry. Path Biol 58:232–238
Birlouez-Aragon I, Saavedra G, Tessier FJ, Galinier A, Ait-Ameur L, Lacoste F, Niamba CN, Alt N, Somoza V, Lecerf JM (2010) A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am J Clin Nutr. doi:10.3945/ajcn.2009.28737
Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H (1994) Modification of low density lipoprotein by advanced glycation endproducts contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA 91:9441–9445
Buetler T (2007) Heated diets, AGEs and tissue dysfunction. IMARS Highlight 2:1–2
Cai W, He JC, Zhu L, Peppa M, Lu C, Uribarri J, Vlassara H (2004) High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients. Circulation 110:285–291
Cai W, He JC, Zhu L, Chen X, Wallenstein S, Striker GE, Vlassara H (2007) Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet. Association with increased AGER1 expression. Am J Pathol 170:1893–1902
Cai W, He JC, Zhu L, Chen X, Zheng F, Striker GE, Vlassara H (2008) Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am J Pathol 173:327–336
Chuyen NV, Arai H, Nakanishi T, Utsunomiya N (2005) Are food advanced glycation end products toxic in biological systems? Ann NY Acad Sci 1043:467–473
Delatour T, Hegele J, Parisod V, Richoz J, Maurer S, Steven M, Buetler T (2009) Analysis of advanced glycation endproducts in dairy products by isotope dilution liquid chromatography-electrospray tandem mass spectrometry. The particular case of carboxymethyllysine. J Chromatogr A 1216:2371–2381
Delgado-Andrade C, Rufián-Henares JA, Morales FJ (2005) Fast method to determine furosine in breakfast cereals by capillary zone electrophoresis. Eur Food Res Technol 221:707–711
Dittrich R, Hoffmann I, Stahl P, Müller A, Beckmann MW, Pischetsrieder M (2006) Concentrations of N ε-carboxymethyllysine in human breast milk, infant formulas, and urine of infants. J Agric Food Chem 54:6924–6928
Dittrich R, Dragonas C, Kannenkeril D, Hoffmann I, Mueller A, Beckmann MW, Pischetsrieder M (2009) A diet rich in Maillard reaction products protects LDL against copper induced oxidation ex vivo, a human intervention trial. Food Res Int 42:1315–1322
Dybing E, Farmer PB, Andersen M, Fennell TR, Lalljie SP, Müller DJ, Olin S, Petersen BJ, Schlatter J, Scholz G, Scimeca JA, Slimani N, Tornqvist M, Tuijtelaars S, Verger P (2005) Human exposure and internal dose assessments of acrylamide in food. Food Chem Toxicol 43:365–410
Erbersdobler HF, Faist V (2001) Metabolic transit of Amadori products. Nahrung 45:177–181
Erbersdobler HF, Somoza V (2007) Forty years of furosine—forty years of using Maillard reaction products as indicators of the nutritional quality of foods. Mol Nutr Food Res 51:423–430
Fenaille F, Parisod V, Visani P, Populaire S, Tabet JC, Guy PA (2006) Modification of milk constituents during processing: a preliminary benchmarking study. Int Dairy J 16:728–739
Förster A, Kühne Y, Henle T (2005) Studies on absorption and elimination of dietary Maillard reaction products. Ann NY Acad Sci 1043:474–481
Goldberg T, Cai W, Peppa M, Dardaine V, Baliga BS, Uribarri J, Vlassara H (2004) Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 104:1287–1291
Henle T (2003) AGEs in foods: do they play a role in uremia? Kidney Int 84:S145–S147
Henle T, Walter A, Haebner R, Klostermeryer H (1994) Detection and identification of a protein-bound imidazolone resulting from the reaction of arginine residues and methylglyoxal. Z Lebensm Unters Forsch 199:55–58
Hofmann SM, Dong HJ, Li Z, Cai W, Altomonte J, Thung SN, Zeng F, Fisher EA, Vlassara H (2002) Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes 51:2082–2089
Karachalias N, Babaei-Jadidi R, Rabbani N, Thornalley P (2010) Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes. Diabetologia 53:1506–1516
Knecht KJ, Dunn JA, Mcfarland KF, McCance DR, Lyons TJ, Thorpe SR, Baynes JW (1991) Effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes 40:190–196
Koschinsky T, He CJ, Mitsuhashi T, Bucala R, Liu C, Buenting C, Heitmann K, Vlassara H (1997) Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA 94:6474–6479
Kroes R, Muller D, Lambe J, Lowik MRH, Klaveren J, Kleiner J, Massey R, Mayer S, Urieta I, Verger P, Visconti A (2002) Assessment of intake from the diet. Food Chem Toxicol 40:327–385
Liardon L, De Weck-Gaudard D, Philippossian G, Finot P-A (1987) Identification of Nepsilon-carboxymethyllysine: a new Maillard reaction product in rat urine. J Agric Food Chem 35:427–431
Lin RY, Choudhury RP, Cai W, Lu M, Fallon JT, Fisher EA, Vlassara H (2003) Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 168:213–220
Marko D, Habermeyer M, Kemeny M, Weyand U, Niederberger E, Frank O, Hofmann T (2003) Maillard reaction products modulating the growth of human tumor cells in vitro. Chem Res Toxicol 16:48–55
Meng J, Sakata N, Takebayashi S, Asano T, Futata T, Nagai R, Ikeda K, Horiuchi S, Myint T, Taniguchi N (1998) Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage. Atherosclerosis 136:355–365
Miyata T, Ueda Y, Horie K, Nangaku M, Tanaka S, de Strihou C, Kurokawa K (1998) Renal catabolism of advanced glycation end products: the fate of pentosidine. Kidney Int 53:416–422
Morales FJ (2009) Hydroxymethylfurfural (HMF) and related compounds. In: Stadler RH, Lineback DR (eds) Process-induced food toxicants: occurrence, formation, mitigation, and health risks. Wiley, New York, pp 135–174
Mucci LA, Wilson KM (2008) Acrylamide intake through diet and human cancer risk. J Agric Food Chem 56:6013–6019
Negrean M, Stirban A, Stratmann B et al (2007) Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr 85:1236–1243
Peppa M, Brem H, Ehrlich P, Zhang JG, Cai W, Li Z, Croitoru A, Thung S, Vlassara H (2003) Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes 52:2805–2813
Pouillart P, Mauprivez H, Ait-Ameur L, Cayzeele A, Lecerf JM, Tessier FJ, Birlouez-Aragon I (2008) Strategy for the study of the health impact of dietary Maillard products in clinical studies: the example of the ICARE clinical study on health adults. Ann NY Acad Sci 1126:173–176
Rabbani N, Sebekova K, Sebekova K Jr, Heidland A, Thornalley PJ (2007) Protein glycation, oxidation and nitration free adduct accumulation after bilateral nephrectomy and ureteral ligation. Kidney Internat 72:1113–1121
Rérat A, Calmes R, Vaissade P, Finot P-A (2002) Nutritional and metabolic consequences of the early Maillard reaction of heat treated milk in the pig. Significance for man. Eur J Nutr 41:1–11
Rufian-Henares JA, Morales FJ (2007) Functional properties of melanoidins: in vitro antioxidant, antimicrobial and antihypertensive activities. Food Res Int 40:995–1002
Sandu O, Song K, Cai W, Zheng F, Uribarri J, Vlassara H (2005) Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. Diabetes 54:2314–2319
Sebeková K, Saavedra G, Zumpe C, Somoza V, Klenovicsová K, Birlouez-Aragon I (2008) Plasma concentration and urinary excretion of N ε-(carboxymethyl)lysine in breast milk- and formula-fed infants. Ann NY Acad Sci 1126:177–180
Seiquer I, Diaz-Alguacil J, Delgado-Andrade C, Lopez-Frias M, Munoz Hoyos A, Galdo G, Navarro MP (2006) Diets rich in Maillard reaction products affect protein digestibility in adolescent males aged 11–14 y. Am J Clin Nutr 83:1082–1088
Somoza V, Wenzel E, Weiss C, Clawin-Radecker I, Grubel N, Erbersdobler HF (2006) Dose-dependent utilisation of casein-linked lysinoalanine, N(epsilon)-fructoselysine and N(epsilon)-carboxymethyllysine in rats. Mol Nutr Food Res 50:833–841
Svistounov D, Smedsrød B (2004) Hepatic clearance of advanced glycation end products (AGEs)-myth or truth? J Hepatol 41:1038–1040
Tareke E, Rydberg P, Karlsson P, Eriksson S, Törnqvist M (2002) Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem 50:4998–5006
Tessier FJ, Niquet C, Rhazi L, Hedhili K, Navarro P, Seiquer I, Delgado-Andrade C (2010) N ε-Carboxymethyllysine: its origin in selected foods and its urinary and faecal excretions in healthy humans. In: Thomas MC, Forbes J (eds) The Maillard reaction. Interface between aging, nutrition and metabolism. Royal Society of Chemistry, London (in press)
Ulbricht RJ, Northup SJ, Thomas JA (1984) A review of 5-hydroxymethylfurfural (HMF) in parenteral solutions. Fundam Appl Toxicol 4:843–853
Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, He C, Vlassara H (2003a) Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J Am Soc Nephrol 14:728–731
Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, Baliga S, Vassalotti JA, Vlassara H (2003b) Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. Am J Kidney Dis 42:532–538
Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, Vlassara H (2007) Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci 62:427–433
Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, Yong A, Striker GE, Vlassara H (2010) Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 110:911–916
Utsunomiya N, Chuyen NV, Kato H (1990) Nutritional and physiological effects of casein modified by glucose, diacetyl, or hexanal. J Nutr Sci Vitaminol 36:387–397
Vlassara H (2005) Advanced glycation in health and disease. Role of the modern environment. Ann NY Acad Sci 1043:452–460
Vlassara H, Cai W, Crandall J, Goldberg T, Oberstein R, Dardaine V, Peppa M, Rayfield EJ (2002) Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA 99:15596–15601
Wadman SK, De Bree PK, Van Sprang FJ, Kamerling JP, Haverkamp J, Vliegenthart JFG (1975) N ε-(Carboxymethyl)lysine, a constituent of human urine. Clin Chim Acta 59:313–320
Zheng F, He C, Cai W, Hattori M, Steffes M, Vlassara H (2002) Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diabetes Metab Res Rev 18:224–237
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tessier, F.J., Birlouez-Aragon, I. Health effects of dietary Maillard reaction products: the results of ICARE and other studies. Amino Acids 42, 1119–1131 (2012). https://doi.org/10.1007/s00726-010-0776-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-010-0776-z